RevitaLash® Cosmetics Sets Ambitious $10 Million Fundraising Goal for Breast Cancer Initiatives

RevitaLash® Cosmetics Sets $10 Million Fundraising Goal

In a significant move to amplify its commitment against breast cancer, RevitaLash® Cosmetics has announced its ambitious goal of raising $10 million for initiatives aimed at combating this disease. This global beauty brand, renowned for its innovative eyelash, eyebrow, and hair care products, is leveraging its influence to make a notable impact in the fight against breast cancer as it prepares to celebrate its 20th anniversary in 2026.

With a proud history of support dating back to its inception, RevitaLash® has already made remarkable strides. The brand reached a milestone in 2024, accumulating $9 million since 2008 in grants and donations related to breast cancer initiatives. Inspired by the legacy of co-founder Gayle Brinkenhoff, who battled breast cancer with strength and grace until her passing, the company seeks to honor her memory and continue the crucial work in this field.

The campaign dubbed “Road to $10 Million” signifies not just a financial target but a heartfelt mission to fund groundbreaking research and comprehensive patient support programs. All year round, RevitaLash donates a portion of every product sold to such causes as part of its 'Eternally Pink®' commitment. Recent projects include pioneering research on triple-negative breast cancer facilitated by the prestigious Francis Crick Institute in London and providing cold cap therapy to assist chemotherapy patients in minimizing hair loss, offered at the Ridley-Tree Cancer Center and UCLA Health in California.

Through collaborations with international partners, RevitaLash aims for the implications of raising $10 million to resonate worldwide. The company pledges to match funds contributed by its distribution partners to designated local charities dedicated to breast cancer support across various communities.

“We are thrilled to announce our goal of raising $10 million and continuing our mission to support breast cancer research and initiatives for patients worldwide,” stated Dariel Sidney, Vice President of Global Philanthropy and daughter of Gayle Brinkenhoff. “Achieving this $10 million goal will not only be a milestone but a celebration of what we stand for as a company.”

Anyone interested in supporting breast cancer initiatives can participate by purchasing RevitaLash products. More information about their efforts and how to contribute can be found on their dedicated page at www.revitalash.com/pages/eternally-pink.

Founded in 2006, RevitaLash® Cosmetics has established itself as a leader in the development of advanced beauty products for eyelash, eyebrow, and hair care. Its award-winning formulations, like the RevitaLash® Advanced eyelash conditioner and RevitaBrow® Advanced eyebrow conditioner, are available in professional settings, spas, beauty salons, and specialized retail stores globally in over 70 countries. Committed to charitable initiatives in the fight against breast cancer, the company invests in research and educational programs benefiting patients tackling this illness year-round, not just during Breast Cancer Awareness Month. For more details about RevitaLash® and its causes, visit www.revitalash.com.